Polymyalgia rheumatica is a relatively common inflammatory rheumatic disease that affects almost exclusively individuals over 60 years of age.

 

It is characterized by the relatively sudden onset of intense pain in the shoulders, neck, and hips, associated with morning stiffness. Some patients describe difficulty in raising their arms in the morning or the sensation of wearing a tight "coat" around their shoulders and neck.

 

The disease often causes significant limitation and can hinder individuals from performing simple daily tasks. Approximately 15% of patients with polymyalgia rheumatica may develop another condition called giant cell arteritis, where vision loss is frequent. For this reason, patients should be vigilant for recent changes in vision, and if this occurs, they should promptly consult their doctor.

 

Treatment involves the rapid initiation of low-dose corticosteroids. Most patients experience a marked improvement in symptoms within a few days of treatment. The average duration of treatment is 18 to 24 months.

 

If left untreated, this disease can lead to severe physical disability. Fortunately, most patients respond very well to the prescribed therapy, and the long-term prognosis is generally good.

 

The experience of the physician is crucial for making the correct diagnosis and managing potential complications associated with the disease and its treatment.
 

Useful links:​

https://spreumatologia.pt/polimialgia-reumatica/

https://www.lpcdr.org.pt/